TOKYO, Oct 14 (Reuters) - Japanese shares retreated on
Wednesday, following Wall Street's fall overnight as stalled
COVID-19 vaccine trials and lack of agreement on additional U.S.
fiscal stimulus weighed on market sentiment.
The benchmark Nikkei share average eased 0.05% to
23,589.35 by the midday break, while the broader Topix
lost 0.51% to 1,640.69.
All but five of the 33 sector sub-indexes on the Tokyo
exchange traded lower, with airlines, iron and steel
and miners leading the decline on the main
On Tuesday, major indexes on Wall Street ended lower as
Johnson & Johnson and Eli Lilly and Co halted
coronavirus vaccine trials over safety concerns, dampening
Fading hopes for a new U.S. coronavirus relief package were
also weighing on the market, as U.S. House Speaker Nancy Pelosi
rejected a $1.8 trillion coronavirus relief proposal from the
Back home, Apple-related issues underperformed on
profit-taking and dented by a 2.7% fall in Apple Inc
shares following an event where the company unveiled its latest
Both TDK Corp and Taiyo Yuden fell about
0.9%, and Murata Manufacturing Corp lost 0.63%.
Financial shares also took a hit from a weak performance in
their U.S. peers, with Sumitomo Mitsui Financial Group
and Mitsubishi UFJ Financial Group down about 1.7%
each, while Mizuho Financial Group slipped 2.67%.
ANA Holdings dipped 3.58% after reports that the
company was going to cut monthly wages for all workers by 5%.
Nippon Steel lost 3.04% on news that the company
would sell two U.S. plants as it speeds up a reorganisation in
Elsewhere, the Mothers Index of start-up firms
(Reporting by Eimi Yamamitsu; Editing by Subhranshu Sahu)